Staphylococcus aureus mutants with increased lysostaphin resistance.
about
Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.The Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus.Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications.Inactivation of the Ecs ABC transporter of Staphylococcus aureus attenuates virulence by altering composition and function of bacterial wallStaphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'Compound-gene interaction mapping reveals distinct roles for Staphylococcus aureus teichoic acids.Bacteriophage endolysins as novel antimicrobials.Expansion of type II CAAX proteases reveals evolutionary origin of γ-secretase subunit APH-1A new platform for ultra-high density Staphylococcus aureus transposon librariesEvolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.Wall teichoic acids of Staphylococcus aureus limit recognition by the drosophila peptidoglycan recognition protein-SA to promote pathogenicity.Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo.Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.Determinants of murein hydrolase targeting to cross-wall of Staphylococcus aureus peptidoglycanABI domain-containing proteins contribute to surface protein display and cell division in Staphylococcus aureusModulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase.Staphylococcus aureus mutants lacking the LytR-CpsA-Psr family of enzymes release cell wall teichoic acids into the extracellular mediumOritavancin binds to isolated protoplast membranes but not intact protoplasts of Staphylococcus aureusIn silico analysis of AHJD-like viruses, Staphylococcus aureus phages S24-1 and S13', and study of phage S24-1 adsorption.Bacterial resistance mechanisms against host defense peptides.Peptidoglycan hydrolases-potential weapons against Staphylococcus aureusIn vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes.VimA-dependent modulation of the secretome in Porphyromonas gingivalis.The effect of skin fatty acids on Staphylococcus aureus.The YjbH adaptor protein enhances proteolysis of the transcriptional regulator Spx in Staphylococcus aureusCharacterization of the staphylococcal bacteriophage lysin CHAP(K).Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.Isobaric tags for relative and absolute quantitation proteomics analysis of gene regulation by SprC in Staphylococcus aureus.Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.SpdC, a novel virulence factor, controls histidine kinase activity in Staphylococcus aureus.Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care.Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing.
P2860
Q30574330-1A0692E1-C47D-4E15-84EE-87C4617C7241Q31111628-C1BC6FFA-1139-4172-AF6C-8FD86CA06690Q33525230-80847EDA-9D65-4FAF-9110-DAFEAC6656F6Q33664443-6B1A45FB-7DD2-4AE5-B5FD-AAC53F7D4B73Q33769673-837DEFFB-F561-48FD-85E3-5072D7667B5BQ33775374-2103037D-B74D-4CFC-9644-D468CFF4CDAEQ34120064-816FD859-2601-4001-8E41-2CF2416EF03DQ34303439-7D0E98B6-C446-4065-BDFD-82F907CCF361Q35161860-B447965C-D6D1-46F9-A060-3F260605FA6AQ35319419-09E062DA-6D11-4453-A412-40E39910D3ACQ35432724-12437687-6E5C-497F-96EA-7C0F174C19D4Q35586976-8CA8ABE4-26E2-4D6F-8395-4F25D40ED424Q35635997-69BDA1B1-860D-43AA-8437-B3CAF6E39117Q35827070-0EFB3914-90AE-42B6-BAAD-1CD76CEB5190Q35880066-F6868ACB-85B9-46F6-B394-37B0166AA7B8Q36513960-DA38C5B4-5C2E-4815-8FBF-1511F45E1C65Q37144963-C7BD87D0-2C95-4273-A455-C42B95272FD8Q37253009-09263962-2303-4ED5-9615-45AD48223DBBQ37355272-C33AFD3B-2287-4B04-B4AB-6975ACD0DAFCQ37718317-3CE84B2A-7B60-40C4-9CC0-271D3DB3E562Q37874201-6617BD2E-81F1-454B-8CC8-20773A2F892EQ38053102-030CE06E-F79C-405D-8814-AA55F9CDA021Q40267392-B062D31F-13C4-48E6-B0EC-8D16A8EF7DD0Q41281749-F469C5A8-2583-45EA-ACA8-F882A578FE98Q42081778-0F75B002-F7D8-4D9B-88CE-E107DDEA6812Q42599145-488A7205-4BE6-4EAA-A0A1-B9EB5D58601BQ44488180-053E38FC-2274-41FF-8A0A-7998A754AE47Q46251747-381F43CA-5025-46F3-9DC1-0E0474B3CB75Q47849662-FDF2BCD8-04CD-407D-B2ED-7579B9667CE8Q49564644-E23993A6-46AB-4B13-B750-AB06587CFF9EQ52653983-8B13C215-3D0C-4DC0-AA4D-96D388EC71BCQ52679093-30D1DA2B-C37E-40DE-82AC-EE14833FE971Q54212204-74574B04-2979-498E-B536-87DA60E05751
P2860
Staphylococcus aureus mutants with increased lysostaphin resistance.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Staphylococcus aureus mutants with increased lysostaphin resistance.
@ast
Staphylococcus aureus mutants with increased lysostaphin resistance.
@en
type
label
Staphylococcus aureus mutants with increased lysostaphin resistance.
@ast
Staphylococcus aureus mutants with increased lysostaphin resistance.
@en
prefLabel
Staphylococcus aureus mutants with increased lysostaphin resistance.
@ast
Staphylococcus aureus mutants with increased lysostaphin resistance.
@en
P2860
P356
P1476
Staphylococcus aureus mutants with increased lysostaphin resistance.
@en
P2093
Dominique M Missiakas
P2860
P304
P356
10.1128/JB.00457-06
P407
P577
2006-09-01T00:00:00Z